Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$9.0 million.

  • InspireMD's Free Cash Flow fell 4641.4% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.1 million, marking a year-over-year decrease of 6544.34%. This contributed to the annual value of -$23.3 million for FY2024, which is 3886.73% down from last year.
  • InspireMD's Free Cash Flow amounted to -$9.0 million in Q3 2025, which was down 4641.4% from -$8.9 million recorded in Q2 2025.
  • InspireMD's Free Cash Flow's 5-year high stood at -$2.6 million during Q2 2021, with a 5-year trough of -$9.2 million in Q1 2025.
  • Over the past 5 years, InspireMD's median Free Cash Flow value was -$4.4 million (recorded in 2023), while the average stood at -$5.1 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 2234.52% in 2023, then tumbled by 8448.95% in 2025.
  • Quarter analysis of 5 years shows InspireMD's Free Cash Flow stood at -$3.0 million in 2021, then dropped by 9.38% to -$3.3 million in 2022, then tumbled by 33.5% to -$4.4 million in 2023, then crashed by 60.77% to -$7.1 million in 2024, then fell by 26.92% to -$9.0 million in 2025.
  • Its last three reported values are -$9.0 million in Q3 2025, -$8.9 million for Q2 2025, and -$9.2 million during Q1 2025.